Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Search

Page Path
HOME > Search
8 "Cheol Min Shin"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Reviews
International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy
Seung Joo Kang, Chung Hyun Tae, Chang Seok Bang, Cheol Min Shin, Young-Hoon Jeong, Miyoung Choi, Joo Ha Hwang, Yutaka Saito, Philip Wai Yan Chiu, Rungsun Rerknimitr, Christopher Khor, Vu Van Khien, Kee Don Choi, Ki-Nam Shim, Geun Am Song, Oh Young Lee, The Korean Society of Gastrointestinal Endoscopy Task Force on Clinical Practice Guidelines
Clin Endosc 2024;57(2):141-157.   Published online March 14, 2024
DOI: https://doi.org/10.5946/ce.2024.002
AbstractAbstract PDFPubReaderePub
Antithrombotic agents, including antiplatelet agents and anticoagulants, are widely used in Korea because of the increasing incidence of cardiocerebrovascular disease and the aging population. The management of patients using antithrombotic agents during endoscopic procedures is an important clinical challenge. The clinical practice guidelines for this issue, developed by the Korean Society of Gastrointestinal Endoscopy, were published in 2020. However, new evidence on the use of dual antiplatelet therapy and direct anticoagulant management has emerged, and revised guidelines have been issued in the United States and Europe. Accordingly, the previous guidelines were revised. Cardiologists were part of the group that developed the guideline, and the recommendations went through a consensus-reaching process among international experts. This guideline presents 14 recommendations made based on the Grading of Recommendations, Assessment, Development, and Evaluation methodology and was reviewed by multidisciplinary experts. These guidelines provide useful information that can assist endoscopists in the management of patients receiving antithrombotic agents who require diagnostic and elective therapeutic endoscopy. It will be revised as necessary to cover changes in technology, evidence, or other aspects of clinical practice.

Citations

Citations to this article as recorded by  
  • Mapping Competence in Gastrointestinal Endoscopy Nursing Practice: An Item Response Theory Analysis of Perceived Skill Acquisition and Maintenance in Italy
    Mattia Bozzetti, Gennaro Pascale, Ilaria Marcomini, Alessio Lo Cascio, Fabio Grilli, Caterina Sclapari, Grazia Multari, Nicoletta Orgiana, Mirko Gaggiotti, Giorgio Iori, Luciana Nicola Giordano, Stefano Mancin, Fabio Petrelli, Giovanni Cangelosi, Loris Ri
    Healthcare.2026; 14(2): 203.     CrossRef
  • EUS-guided gallbladder drainage for patients with antithrombotic therapy: Intervention or medication?
    Liqi Sun, Jiang Liu
    Gastrointestinal Endoscopy.2025; 101(1): 226.     CrossRef
  • Do all antithrombotic agents have a similar impact on small bowel bleeding?
    Chung Hyun Tae, Ki-Nam Shim
    Clinical Endoscopy.2025; 58(1): 80.     CrossRef
  • Response
    Tae-Geun Gweon, Hyun Gun Kim
    Gastrointestinal Endoscopy.2025; 101(4): 925.     CrossRef
  • Medical disputes involving lower gastrointestinal endoscopies: cases from the Korean Medical Dispute Mediation and Arbitration Agency
    Eun Hye Oh, Jeong Eun Shin, Jun Yong Bae, Yoon Suk Lee, Yehyun Park, Yong Hwan Kwon, Chang Nyol Paik, Jun Kyu Lee, Tae Hee Lee
    The Korean Journal of Internal Medicine.2025; 40(3): 404.     CrossRef
  • Contemporary approaches in the peri-endoscopic management of antithrombotic agents: current paradigms, challenges, and prognostications
    Jiaxuan Zuo, Wei Jiang, Lumei Wang, Kaiqi Yang, Peng Li, Shutian Zhang, Rui Cheng
    Therapeutic Advances in Gastroenterology.2025;[Epub]     CrossRef
  • Prediction of immediate bleeding after cold snare polypectomy: A prospective observational study
    Shin Ju Oh, Yunho Jung, Young Hwangbo, Young Sin Cho, Il Kwun Chung, Chang Kyun Lee
    Medicine.2024; 103(36): e39597.     CrossRef
  • 22,596 View
  • 788 Download
  • 7 Web of Science
  • 7 Crossref
Close layer
Clinical practice guidelines for percutaneous endoscopic gastrostomy
Chung Hyun Tae, Ju Yup Lee, Moon Kyung Joo, Chan Hyuk Park, Eun Jeong Gong, Cheol Min Shin, Hyun Lim, Hyuk Soon Choi, Miyoung Choi, Sang Hoon Kim, Chul-Hyun Lim, Jeong-Sik Byeon, Ki-Nam Shim, Geun Am Song, Moon Sung Lee, Jong-Jae Park, Oh Young Lee, Korean Society of Gastrointestinal Endoscopy Task Force on Clinical Practice Guidelines
Clin Endosc 2023;56(4):391-408.   Published online June 23, 2023
DOI: https://doi.org/10.5946/ce.2023.062
AbstractAbstract PDFSupplementary MaterialPubReaderePub
With an aging population, the number of patients with difficulty in swallowing due to medical conditions is gradually increasing. In such cases, enteral nutrition is administered through a temporary nasogastric tube. However, the long-term use of a nasogastric tube leads to various complications and a decreased quality of life. Percutaneous endoscopic gastrostomy (PEG) is the percutaneous placement of a tube into the stomach that is aided endoscopically and may be an alternative to a nasogastric tube when enteral nutritional is required for four weeks or more. This paper is the first Korean clinical guideline for PEG developed jointly by the Korean College of Helicobacter and Upper Gastrointestinal Research and led by the Korean Society of Gastrointestinal Endoscopy. These guidelines aimed to provide physicians, including endoscopists, with the indications, use of prophylactic antibiotics, timing of enteric nutrition, tube placement methods, complications, replacement, and tube removal for PEG based on the currently available clinical evidence.

Citations

Citations to this article as recorded by  
  • A Case of Perforated Peritonitis Caused by the Migration of a Single‐Puncture Gastric Wall Fixation Device Following Percutaneous Endoscopic Gastrostomy
    Yuu Kodama, Yuji Mizokami, Hidemitsu Nishizawa, Gen Maeda, Gen Kimura, Yuzo Toyama, Shingo Asahara, Ryuji Nagahama, Hideki Sunagawa
    DEN Open.2026;[Epub]     CrossRef
  • Comparative Analysis of Conventional Ideal Button Versus New Ideal Button ZERO for Percutaneous Endoscopic Gastrostomy Catheter Replacement
    Kazuya Miyaguchi, Hisashi Matsumoto, Yuki Shiko, Yoshikazu Tsuzuki, Maiko Osawa, Rie Shiomi, Keiji Yamamoto, Yohei Kawasaki, Hiroyuki Imaeda
    DEN Open.2026;[Epub]     CrossRef
  • Buried Balloon Syndrome After Percutaneous Radiologic Gastrostomy: Two Case Reports and a Literature Review
    Ik-Tae Kwon, Hyoung Nam Lee, Youngjong Cho, Seung Soo Kim, Chan Ho Park, Hyerim Park
    Journal of the Korean Society of Radiology.2026; 87(1): 157.     CrossRef
  • Percutaneous endoscopic gastrostomy complications and management
    Rıdvan Sivritepe, Güldan Kahveci, Rana Basat
    Discover Medicine.2026;[Epub]     CrossRef
  • Early mortality and adverse health outcomes after percutaneous endoscopic gastrostomy placement in palliative care patients
    Mehmet Erdevir, Dilara Dönmez Güler, Esra Ateş Bulut
    Cukurova Medical Journal.2026; 51(1): 116.     CrossRef
  • Complications Post Gastrostomy Insertion in Patients with Head and Neck Cancer: A Systematic Review
    A.C. Rogers, C.L. Blake, R. Willims, J. Bauer, M. Appleyard, T.E. Brown
    Clinical Oncology.2026; 53: 104096.     CrossRef
  • A systematic review and quality appraisal of guidelines and recommendations for home enteral tube feeding in adults
    Andriana Korai, Isabella Thomson, Sharon Carey, Margaret Allman-Farinelli
    European Journal of Clinical Nutrition.2025; 79(2): 104.     CrossRef
  • One-Year Mortality After Percutaneous Endoscopic Gastrostomy: The Prognostic Role of Nutritional Biomarkers and Care Settings
    Nermin Mutlu Bilgiç, Güldan Kahveci, Ekmel Burak Özşenel, Sema Basat
    Nutrients.2025; 17(5): 904.     CrossRef
  • Malnutrition and perioperative nutritional rehabilitation in major operations
    Konstantinos Lasithiotakis, Alexandros Andreou, Hammam Migdadi, Evangelos I. Kritsotakis
    European Surgery.2025; 57(5): 188.     CrossRef
  • Endoscopic gastrostomy as a method of enteral nutrition providing
    E. A. Drobyazgin, Yu. V. Chikinev, A. V. Korobeynikov, A. S. Polyakevich, I. V. Peshkova, S. G. Stofin
    Filin’s Clinical endoscopy.2025; 67(1): 54.     CrossRef
  • Clinical Advances in Percutaneous Endoscopic Gastrostomy: A 2023 Clinical Practice Guideline-Based Review
    Ji Yong Ahn
    The Korean Journal of Medicine.2025; 100(2): 54.     CrossRef
  • Timing of Gastrostomy Relative to Tracheostomy After Complete Cervical Spinal Cord Injury: Impact on Hospitalization Outcomes and Complication Rates
    Ahmad Essa, Armaan K. Malhotra, Husain Shakil, Avery B. Nathens, Eva Y. Yuan, Yingshi He, Francois Mathieu, Michael C. Sklar, Jefferson R. Wilson, Christopher D. Witiw, Jetan H. Badhiwala
    Neurosurgery.2025; 97(6): 1286.     CrossRef
  • Outcomes of early compared with delayed initiation of feeding after placement of percutaneous endoscopic gastrostomy tube: A systematic review and meta‐analysis
    Mudathir Ibrahim, Ceilidh McKenney, Camilla Sophia Rossi, Susan Khader Ibrahim, Ahmed Alnajar, Gianmarco Cancelli, Matthew McKenney, Michelle Demetres, Zi Yuan, Jeffrey Nicastro, Joel Horovitz
    Journal of Parenteral and Enteral Nutrition.2025; 49(6): 682.     CrossRef
  • Predictors of failure of percutaneous endoscopic gastrostomy tube placement: a retrospective study in a tertiary care center in the USA
    Ryan Xin, Cassandra Sanossian, Melissa Fazzari, Brandon Mui, Marouf Hossain, Jennifer Katz
    Clinical Endoscopy.2025; 58(3): 418.     CrossRef
  • Gastric outlet and duodenal bulb obstruction: A rare complication due to migrated gastrostomy tube
    Merve Eren Durmuş, Serkan Öcal, Ayhan Hilmi Çekin, Gökhan Köker
    Geriatric Nursing.2025; 65: 103426.     CrossRef
  • Mortalidad y futilidad en pacientes a quienes se les realizó gastrostomía entre 2020 a 2023
    Oscar Mauricio Ardila Suárez, Erick Ricardo Licona Vera, Sebastián Fernando Niño Ramírez
    Revista colombiana de Gastroenterología.2025; 40(2): 160.     CrossRef
  • Challenges, Perceptions, Training and Needs of Primary Care Nurses in the Management of Patients with Percutaneous Endoscopic Gastrostomy: A Cross-Sectional Study in Southern Spain
    María de los Santos Oñate-Tenorio, Nuria Trujillo-Garrido, María de los Ángeles Bernal-Jiménez, María José Santi-Cano
    Healthcare.2025; 13(21): 2786.     CrossRef
  • Single-step replacement of a push-type PEG with a pull-type PEG in a patient with dysphagia
    Soo Bin Synn, Su Jin Kim
    Journal of Innovative Medical Technology.2025; 3(2): 66.     CrossRef
  • Evaluation of Electrolyte Imbalances and Their Impact on Mortality in Percutaneous Endoscopic Gastrostomy Patients in the Emergency Department
    Ali Sarıdaş, Naile Fevziye Mısırlıoglu, Nedim Uzun, Türker Acehan, Sumeyye Nur Aydin, Aysun Ekinci, Hafize Uzun
    Dicle Tıp Dergisi.2025; 52(4): 659.     CrossRef
  • Predictors of Percutaneous Endoscopic Gastrostomy‐Related Complications in Amyotrophic Lateral Sclerosis: A 19‐Year Retrospective Study From a Tertiary Center
    Sang Pyo Lee, Jaeyoung Choi, Jin Hwa Park, Kang Nyeong Lee, Hang Lak Lee, Wonjae Sung
    Journal of Digestive Diseases.2025; 26(11-12): 492.     CrossRef
  • A Multicenter Survey of Percutaneous Endoscopic Gastrostomy in 2019 at Korean Medical Institutions
    Jun Woo Park, Tae Gyun Kim, Kwang Bum Cho, Jeong Seok Kim, Jin Woong Cho, Jung Won Jeon, Sun Gyo Lim, Chan Gyoo Kim, Hong Jun Park, Tae Jun Kim, Eun Sun Kim, Su Jin Jeong, Yong Hwan Kwon
    Gut and Liver.2024; 18(1): 77.     CrossRef
  • Fast-track discharge following percutaneous endoscopic gastrostomy removal in head and neck cancer patients after remission: a feasibility and safety study
    Daniel Conceição, Luís Correia Gomes, Fátima Francisco, Ivone Frade, Joana Gramacho, Sandra Faias, Isabel Claro
    Journal of Gastrointestinal Surgery.2024; 28(6): 943.     CrossRef
  • When to feed after percutaneous endoscopic gastrostomy: A systematic review and meta‐analysis of randomized controlled trials
    Matthew L. Bechtold, Zahid Ijaz Tarar, Muhammad N. Yousaf, Ghady Moafa, Abdul M. Majzoub, Xheni Deda, Michelle L. Matteson‐Kome, Srinivas R. Puli
    Nutrition in Clinical Practice.2024; 39(5): 1191.     CrossRef
  • The Effect of Oral Diet Training in Indwelling Nasogastric Tube Patients with Prolonged Dysphagia
    Byung-chan Choi, Sook Joung Lee, Eunseok Choi, Sangjee Lee, Jungsoo Lee
    Nutrients.2024; 16(15): 2424.     CrossRef
  • The Impact of Palliative Decompressive Gastrostomy Tube Placement on Patients and Their Caregivers: A Mixed Methods Analysis
    Jeffrey L. Roberson, Julia A. Gasior, Sara P. Ginzberg, Emna Bakillah, Jesse Passman, Lauren Shreve, Catherine E. Sharoky, Gregory Nadolski, Katherine R. Courtright, Elinore J. Kaufman
    Annals of Surgical Oncology.2024; 31(10): 6931.     CrossRef
  • 20,634 View
  • 855 Download
  • 21 Web of Science
  • 25 Crossref
Close layer
Clinical Practice Guideline for the Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy
Hyun Lim, Eun Jeong Gong, Byung-Hoon Min, Seung Joo Kang, Cheol Min Shin, Jeong-Sik Byeon, Miyoung Choi, Chan Guk Park, Joo Young Cho, Soo Teik Lee, Ho Gak Kim, Hoon Jai Chun
Clin Endosc 2020;53(6):663-677.   Published online November 26, 2020
DOI: https://doi.org/10.5946/ce.2020.192
AbstractAbstract PDFPubReaderePub
Antithrombotic agents, including antiplatelet agents and anticoagulants, are increasingly used in South Korea. The management of patients using antithrombotic agents and requiring gastrointestinal endoscopy is an important clinical challenge. Although clinical practice guidelines (CPGs) for the management of patients receiving antithrombotic agents and undergoing gastrointestinal endoscopy have been developed in the Unites States, Europe, and Asia Pacific region, it is uncertain whether these guidelines can be adopted in South Korea. After reviewing current CPGs, we identified unmet needs and recognized significant discrepancies in the clinical practice among regions. This is the first CPG in Korea providing information that may assist endoscopists in the management of patients on antithrombotic agents who require diagnostic or elective therapeutic endoscopy. This guideline was developed through the adaptation process as an evidence-based method, with four guidelines retrieved by systematic review. Eligible guidelines were evaluated according to the Appraisal of Guidelines for Research and Evaluation II process, and 13 statements were established using a grading system. This guideline was reviewed by external experts before an official. It will be revised as necessary to cover changes in technology, evidence, or other aspects of clinical practice.

Citations

Citations to this article as recorded by  
  • Surgical and procedural bleed risk stratification for anticoagulated patients undergoing planned surgery: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis
    Joseph R. Shaw, Jameel Abdulrehman, Steffan Frosi Stella, Grigorios I. Leontiadis, Jan Steffel, Maria P. Ntalouka, Guillaume Martel, Kari A.O. Tikkinen, Prism Schneider, Mark Turrentine, Achilleas Thoma, Daniel Lee, Adam P.J.J. Bray, Nick Blanas, Edsel In
    Journal of Thrombosis and Haemostasis.2026;[Epub]     CrossRef
  • Reproducibility of the AGREE II Tool for Assessing the Methodological Quality of Clinical Practice Guidelines for the Management of Antithrombotic Agents in Patients Undergoing GI Endoscopy
    Denisse Camille Dayto, Wojciech Blonski, Tea Reljic, Farina Klocksieben, Jeffrey Gill, Rene D. Gomez-Esquivel, Brijesh Patel, Pushpak Taunk, Andrew Sephien, Camille Thelin, Ambuj Kumar
    Journal of Clinical Gastroenterology.2025; 59(5): 443.     CrossRef
  • Safety of cold snare resection techniques for removal of polyps in the small colon in patients taking clopidogrel and aspirin: a Korean Association for the Study of Intestinal Diseases prospective multicenter study
    Tae-Geun Gweon, Hyun Gun Kim, Yunho Jung, Seong Ran Jeon, Soo-Young Na, Yoo Jin Lee, Tae Ho Kim
    Gastrointestinal Endoscopy.2025; 101(4): 866.     CrossRef
  • Chronic Kidney Disease Increases Risk of Delayed Post‐Polypectomy Bleeding: A Large‐Scale Propensity Score‐Matched Analysis
    Hye Kyung Hyun, Nak‐Hoon Son, So Hyeon Gwon, Hyun Chul Lim, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Tae‐Hyun Yoo, Shin‐Wook Kang, Hae‐Ryong Yun, Cheal Wung Huh
    United European Gastroenterology Journal.2025; 13(5): 759.     CrossRef
  • Clinical Advances in Percutaneous Endoscopic Gastrostomy: A 2023 Clinical Practice Guideline-Based Review
    Ji Yong Ahn
    The Korean Journal of Medicine.2025; 100(2): 54.     CrossRef
  • Minimum Platelet Count Threshold for Safe Colonoscopic Polypectomy: A Large-Scale Propensity Scored-Matched Analysis
    Hye Kyung Hyun, Nak-Hoon Son, Cheal Wung Huh, Hyun Chul Lim, So Hyeon Gwon, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
    American Journal of Gastroenterology.2025; 120(12): 2918.     CrossRef
  • Management for endoscopic procedures in patients taking antithrombotic agents
    Chung Hyun Tae, Ki-Nam Shim
    Journal of the Korean Medical Association.2025; 68(8): 536.     CrossRef
  • Clinical Practice Guideline for Percutaneous Endoscopic Gastrostomy
    Chung Hyun Tae, Ju Yup Lee, Moon Kyung Joo, Chan Hyuk Park, Eun Jeong Gong, Cheol Min Shin, Hyun Lim, Hyuk Soon Choi, Miyoung Choi, Sang Hoon Kim, Chul-Hyun Lim, Jeong-Sik Byeon, Ki-Nam Shim, Geun Am Song, Moon Sung Lee, Jong-Jae Park, Oh Young Lee
    Gut and Liver.2024; 18(1): 10.     CrossRef
  • A systematic critical appraisal of clinical practice guidelines of antithrombotic agents in gastrointestinal endoscopy using the AGREE II tool
    Denisse Camille Dayto, Wojciech Blonski, Tea Reljic, Farina Klocksieben, Jeffrey Gill, Rene D. Gomez‐Esquivel, Brijesh Patel, Pushpak Taunk, Andrew Sephien, Camille Thelin, Ambuj Kumar
    Journal of Gastroenterology and Hepatology.2024; 39(5): 818.     CrossRef
  • The Impact of Sedation on Cardio-Cerebrovascular Adverse Events after Surveillance Esophagogastroduodenoscopy in Patients with Gastric Cancer: A Nationwide Population-Based Cohort Study
    Sang Yoon Kim, Jun Kyu Lee, Kwang Hyuck Lee, Jae-Young Jang, Byung-Wook Kim
    Gut and Liver.2024; 18(2): 245.     CrossRef
  • International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy
    Seung Joo Kang, Chung Hyun Tae, Chang Seok Bang, Cheol Min Shin, Young-Hoon Jeong, Miyoung Choi, Joo Ha Hwang, Yutaka Saito, Philip Wai Yan Chiu, Rungsun Rerknimitr, Christopher Khor, Vu Van Khien, Kee Don Choi, Ki-Nam Shim, Geun Am Song, Oh Young Lee
    Clinical Endoscopy.2024; 57(2): 141.     CrossRef
  • Top tips on the management of antithrombotic agents in the periendoscopic period
    Alberto Tringali
    Gastrointestinal Endoscopy.2024; 99(6): 1021.     CrossRef
  • IDEN Consensus on Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy
    Seung Joo Kang, Chung Hyun Tae, Chang Seok Bang, Cheol Min Shin, Young-Hoon Jeong, Miyoung Choi, Joo Ha Hwang, Yutaka Saito, Philip Wai Yan Chiu, Rungsun Rerknimitr, Christopher Khor, Vu Van Khien, Kee Don Choi, Ki-Nam Shim, Geun Am Song, Oh Young Lee
    The Korean Journal of Gastroenterology.2024; 83(6): 217.     CrossRef
  • Anticoagulants Are a Risk Factor for Delayed Bleeding after Colorectal Endoscopic Submucosal Dissection: A HASID Multicenter Study
    Seong-Jung Kim, Jun Lee, Hyo-Yeop Song, Geom Seog Seo, Byung Chul Jin, Sang-Wook Kim, Dong Hyun Kim, Hyun-Soo Kim, Hyung-Hoon Oh, Dae-Seong Myung, Young-Eun Joo
    Digestion.2024; 105(5): 389.     CrossRef
  • Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
    Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
    Korean Journal of Radiology.2024; 25(9): 773.     CrossRef
  • Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
    Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
    Gut and Liver.2024; 18(5): 789.     CrossRef
  • International Digestive Endoscopy Network Consensus on the Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy
    Seung Joo Kang, Chung Hyun Tae, Chang Seok Bang, Cheol Min Shin, Young-Hoon Jeong, Miyoung Choi, Joo Ha Hwang, Yutaka Saito, Philip Wai Yan Chiu, Rungsun Rerknimitr, Christopher Khor, Vu Van Khien, Kee Don Choi, Ki-Nam Shim, Geun Am Song, Oh Young Lee
    Gut and Liver.2024; 18(5): 764.     CrossRef
  • Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association
    Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
    Journal of Liver Cancer.2024; 24(2): 131.     CrossRef
  • Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology – 2024
    Danielle Menosi Gualandro, Luciana Savoy Fornari, Bruno Caramelli, Alexandre Antonio Cunha Abizaid, Brenno Rizerio Gomes, Caio de Assis Moura Tavares, Caio Julio Cesar dos Santos Fernandes, Carisi Anne Polanczyk, Carlos Jardim, Carolina Leticia Zilli Viei
    Arquivos Brasileiros de Cardiologia.2024;[Epub]     CrossRef
  • Diretriz de Avaliação Cardiovascular Perioperatória da Sociedade Brasileira de Cardiologia – 2024
    Danielle Menosi Gualandro, Luciana Savoy Fornari, Bruno Caramelli, Alexandre Antonio Cunha Abizaid, Brenno Rizerio Gomes, Caio de Assis Moura Tavares, Caio Julio Cesar dos Santos Fernandes, Carisi Anne Polanczyk, Carlos Jardim, Carolina Leticia Zilli Viei
    Arquivos Brasileiros de Cardiologia.2024;[Epub]     CrossRef
  • Assessment of delayed bleeding after endoscopic submucosal dissection of early-stage gastrointestinal tumors in patients receiving direct oral anticoagulants
    Mitsushige Sugimoto, Masaki Murata, Takashi Kawai
    World Journal of Gastroenterology.2023; 29(19): 2916.     CrossRef
  • Clinical practice guidelines for percutaneous endoscopic gastrostomy
    Chung Hyun Tae, Ju Yup Lee, Moon Kyung Joo, Chan Hyuk Park, Eun Jeong Gong, Cheol Min Shin, Hyun Lim, Hyuk Soon Choi, Miyoung Choi, Sang Hoon Kim, Chul-Hyun Lim, Jeong-Sik Byeon, Ki-Nam Shim, Geun Am Song, Moon Sung Lee, Jong-Jae Park, Oh Young Lee
    Clinical Endoscopy.2023; 56(4): 391.     CrossRef
  • Clinical Practice Guideline for Percutaneous Endoscopic Gastrostomy
    Chung Hyun Tae, Ju Yup Lee, Moon Kyung Joo, Chan Hyuk Park, Eun Jeong Gong, Cheol Min Shin, Hyun Lim, Hyuk Soon Choi, Miyoung Choi, Sang Hoon Kim, Chul-Hyun Lim, Jeong-Sik Byeon, Ki-Nam Shim, Geun Am Song, Moon Sung Lee, Jong-Jae Park, Oh Young Lee
    The Korean Journal of Gastroenterology.2023; 82(3): 107.     CrossRef
  • Predicting the Bleeding Risk for Patients on Anticoagulant Therapy Prior to Gastric Endoscopic Submucosal Dissection
    Jie-Hyun Kim
    Journal of Gastric Cancer.2022; 22(1): 1.     CrossRef
  • Utility of a deep learning model and a clinical model for predicting bleeding after endoscopic submucosal dissection in patients with early gastric cancer
    Ji Eun Na, Yeong Chan Lee, Tae Jun Kim, Hyuk Lee, Hong-Hee Won, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Jae J Kim
    World Journal of Gastroenterology.2022; 28(24): 2721.     CrossRef
  • 21,796 View
  • 1,087 Download
  • 23 Web of Science
  • 25 Crossref
Close layer
Commentarys
Close layer
Is Percutaneous Endoscopic Gastrostomy Acceptable in Centenarian Patients?
Cheol Min Shin, Dong Ho Lee
Clin Endosc 2018;51(1):1-2.   Published online January 31, 2018
DOI: https://doi.org/10.5946/ce.2018.018
PDFPubReaderePub
  • 6,912 View
  • 139 Download
Close layer
Original Articles
Correlation of Endoscopic Findings of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma with Recurrence after Complete Remission
Chang Min Lee, Dong Ho Lee, Byung Kyu Ahn, Jae Jin Hwang, Hyuk Yoon, Young Soo Park, Cheol Min Shin, Nayoung Kim
Clin Endosc 2017;50(1):51-57.   Published online March 24, 2016
DOI: https://doi.org/10.5946/ce.2016.015
AbstractAbstract PDFPubReaderePub
Background
/Aims: In gastric mucosa-associated lymphoid tissue (MALT) lymphoma, the clinical significance of various endoscopic findings has not yet been determined. This study aimed to compare the time to complete remission (CR) and relapse-free survival (RFS) in gastric MALT lymphoma based on endoscopic findings.
Methods
In this single-center retrospective cohort study, the medical records of 122 consecutive adult patients with gastric MALT lymphoma were collected over a period of 12 years. CR was defined by the absence of macroscopic or microscopic features of lymphoma on two subsequent follow-ups. Relapse was clinically defined by a positive endoscopic biopsy after CR.
Results
The median time to CR did not differ significantly between treatment methods. However, it was significantly longer in the group with polypoid endoscopic appearance than in the groups with diffuse infiltration or ulceration (7.83, 3.43, and 3.10 months, respectively; p=0.003). Six patients relapsed after CR. Kaplan-Meier analysis showed that RFS differed significantly between groups based on Ann Arbor staging, treatment methods, and initial endoscopic findings.
Conclusions
In gastric MALT lymphoma, the endoscopically defined polypoid type was characterized by a longer duration to CR, with a higher likelihood of recurrence, compared to the endoscopically defined diffuse infiltration or ulceration types.

Citations

Citations to this article as recorded by  
  • A Case of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma with Special Endoscopic Morphology
    Xin Sun, Yanbo Zhen, Pan Pan, Liang Liu
    Journal of Digestive Endoscopy.2025; 16(02): 100.     CrossRef
  • Characteristic endoscopic findings of gastrointestinal malignant lymphomas other than mucosa-associated lymphoid tissue lymphoma
    T Kanno, T Katano, T Shimura, R Nishigaki, Y Kojima, M Sasaki, Y Okuda, N Sugimura, S Fukusada, Y Mizuno, H Iwasaki, H Nishie, M Tanaka, K Ozeki, E Kubota, S Tanida, H Kataoka
    Acta Gastro Enterologica Belgica.2022; 85(3): 477.     CrossRef
  • Diagnosis and Treatment for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
    Shotaro Nakamura, Mariko Hojo
    Journal of Clinical Medicine.2022; 12(1): 120.     CrossRef
  • Normal gastrointestinal tract inflammatory cells and review of select benign hematolymphoid proliferations
    Jennifer Y. Ju, Edward B. Stelow, Elizabeth L. Courville
    Seminars in Diagnostic Pathology.2021; 38(4): 6.     CrossRef
  • Optimal Initial Workup in Patients With Superficial Primary Gastric MALT Lymphoma
    Hee Kyong Na, Sung Hyun Won, Jeong Hoon Lee, Ga Hee Kim, Kee Wook Jung, Ji Yong Ahn, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung
    Journal of Clinical Gastroenterology.2021; 55(9): 785.     CrossRef
  • Endoscopic features and clinical outcomes of colorectal mucosa-associated lymphoid tissue lymphoma
    Min Kyung Jeon, Hoonsub So, Jooryung Huh, Hee Sang Hwang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kee Don Choi, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
    Gastrointestinal Endoscopy.2018; 87(2): 529.     CrossRef
  • Endoscopic Findings of Gastric Extranodal Marginal Zone B-Cell Mucosa-Associated Lymphoid Tissue Lymphoma
    Sang Kil Lee
    Clinical Endoscopy.2017; 50(1): 1.     CrossRef
  • 12,397 View
  • 243 Download
  • 7 Web of Science
  • 7 Crossref
Close layer
Low Grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma: Clinicopathological Factors Associated with Helicobacter pylori Eradication and Tumor Regression
Yoon Jin Choi, Dong Ho Lee, Ji Yeon Kim, Ji Eun Kwon, Jae Yeon Kim, Hyun Jin Jo, Cheol Min Shin, Hyun Young Kim, Young Soo Park, Nayoung Kim, Hyun Chae Jung, In Sung Song
Clin Endosc 2011;44(2):101-108.   Published online December 31, 2011
DOI: https://doi.org/10.5946/ce.2011.44.2.101
AbstractAbstract PDFPubReaderePub
Background/Aims

Eradication of Helicobacter pylori is widely accepted as initial therapy for low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma. However, approximately 20% of patients with this disease are not responsive to H. pylori eradication therapy. The aim of this study was to assess remission and relapse rates of low-grade gastric MALT lymphoma after H. pylori eradication and identify the clinical factors that affect remission.

Methods

Thirty-nine patients diagnosed with gastric MALT lymphoma (May 2003 to May 2010) were retrospectively analyzed.

Results

Of the 39 patients, 30 (77%) had a H. pylori infection. There were 35/39 (90%) patients with stage I. Among stage I, 25 patients with the infection underwent eradication therapy and 22/25 (88%) achieved remission. The total regression rate with eradication only in stage I was 24/28 (86%). The median time to remission was 98 days (range, 22 to 397 days). Age, tumor location, invasion depth, H. pylori burden, and severity of mononuclear leukocyte and neutrophil infiltration were not related to remission. However, patients with less neutrophil infiltration were more likely to achieve a successful first H. pylori eradication (p=0.049).

Conclusions

The results show that the rate of low-grade gastric MALT lymphoma regression (86%) with H. pylori eradication alone was higher than that in Western studies (77.8%) and that neutrophil infiltration was inversely related to success of the first H. pylori eradication procedure.

Citations

Citations to this article as recorded by  
  • Value of endoscopic submucosal dissection in diagnosing gastric mucosa-associated lymphoid tissue lymphoma: A case report
    Shuo-Hui Li, Wei-Wei Niu, Xiao-Xia Huo, Hong Zhang, Li-Min Shi, Ya-Ting Liu, Jia-Jing Xing, Zhi-Xin Feng, Na Wang
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Effectiveness of Helicobacter pylori eradication in the treatment of early-stage gastric mucosa-associated lymphoid tissue lymphoma: An up-to-date meta-analysis
    Fabian Fellipe Bueno Lemos, Caroline Tianeze de Castro, Mariana Santos Calmon, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Clara Faria Souza Mendes dos Santos, Gabriel Lima Correa Santos, Hanna Santos Marques, Henrique Affonso Delgado, Kádima Nayara Tei
    World Journal of Gastroenterology.2023; 29(14): 2202.     CrossRef
  • Efficacy of eradication therapy in Helicobacter pylori‐negative gastric mucosa‐associated lymphoid tissue lymphoma: A meta‐analysis
    Kyoungwon Jung, Do Hoon Kim, Hyun Il Seo, Eun Jeong Gong, Chang Seok Bang
    Helicobacter.2021;[Epub]     CrossRef
  • Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis
    Ya-Lin Xie, Chun-Yan He, Si-Qi Wei, Wen-Ju Guan, Zheng Jiang
    Chinese Medical Journal.2020; 133(11): 1337.     CrossRef
  • Clinical Efficacy of Radiotherapy inHelicobacter pyloriNegative or Unresponsive to Eradication Therapy Primary Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
    Byung Sam Park, Si Hyung Lee
    The Korean Journal of Gastroenterology.2019; 73(1): 19.     CrossRef
  • Endoscopic features aiding the diagnosis of gastric mucosa-associated lymphoid tissue lymphoma
    Byung Sam Park, Si Hyung Lee
    Yeungnam University Journal of Medicine.2019; 36(2): 85.     CrossRef
  • Bone marrow involvement is not associated with the clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma
    Eun Jeong Gong, Ji Yong Ahn, Hwoon-Yong Jung, Kyoungwon Jung, Charles J. Cho, Hee Kyong Na, Kee Wook Jung, Do Hoon Kim, Jeong Hoon Lee, Kee Don Choi, Ho June Song, Gin Hyug Lee, Jin-Ho Kim, Dok Hyun Yoon
    Scandinavian Journal of Gastroenterology.2016; 51(8): 942.     CrossRef
  • Helicobacter pyloriEradication Therapy Is Effective as the Initial Treatment for Patients withH. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
    Eun Jeong Gong, Ji Yong Ahn, Hwoon-Yong Jung, Hyungchul Park, Young Bo Ko, Hee Kyong Na, Kee Wook Jung, Do Hoon Kim, Jeong Hoon Lee, Kee Don Choi, Ho June Song, Gin Hyug Lee, Jin-Ho Kim
    Gut and Liver.2016; 10(5): 706.     CrossRef
  • Antisecretory medication is associated with decreased Helicobacter pylori detection in gastric marginal zone lymphoma
    Kurt B. Schaberg, Mark F. Evans, Rebecca Wilcox, Michael R. Lewis
    Annals of Diagnostic Pathology.2015; 19(6): 397.     CrossRef
  • A Polypoid Mucosa-Associated Lymphoid Tissue Lymphoma of the Stomach Treated with Endoscopic Polypectomy
    Shin Young Min, Jun Haeng Lee, Poong-Lyul Rhee
    Clinical Endoscopy.2013; 46(6): 647.     CrossRef
  • 10,458 View
  • 57 Download
  • 10 Crossref
Close layer
Dual Therapy Trial Using Esomeprazole and Amoxicillin as Third-line Rescue Therapy for Helicobacter pylori Infection
Hyun Kyung Park, Dong Ho Lee, Seungchul Suh, Pyoung Ju Seo, Nayoung Kim, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Hyeok Hwang, Young Soo Park, Sang Hyub Lee, Cheol Min Shin
Clin Endosc 2011;44(1):33-37.   Published online September 30, 2011
DOI: https://doi.org/10.5946/ce.2011.44.1.33
AbstractAbstract PDFPubReaderePub
Background/Aims

The purpose of this study was to evaluate the efficacy and tolerability of dual therapy consisting of esomeprazole and amoxicillin as a rescue therapy for Helicobacter pylori infection.

Methods

From December 2009 to August 2010, 21 patients who experienced two consecutive eradication failures were included. They received esomeprazole (40 mg, b.i.d.) and amoxicillin (1,000 mg, b.i.d.) for 14 days as a third eradication regimen. Compliance and side effects were determined from an interview. H. pylori status was evaluated using the 13C urea breath test at least 6 weeks after treatment.

Results

The mean age of the patients was 59 years and included 52% males. Indications for treatment were functional dyspepsia (61.9%), peptic ulcer disease (28.6%), and gastric adenoma (9.5%). H. pylori was eradicated in 14 of 21 (66.7%) patients. Minor side effects were reported in three of the 21 patients (14.3%). These side effects consisted mainly of nausea and epigastric discomfort.

Conclusions

A 2-week course of dual therapy failed to show satisfactory results in third-line H. pylori eradication, but it was very safe and tolerable. Therefore, dual therapy constitutes an encouraging empirical strategy for the elderly and infirm patients with multiple previous eradication failures.

Citations

Citations to this article as recorded by  
  • Treatment of Helicobacter pylori Infection in Korea: An Evidence-Based Analysis of the Upcoming 2025 Guideline
    Chang Seok Bang, Seung Joo Kang, Su Youn Nam, Sung Eun Kim, Seung Young Kim, Hyunchul Lim, Chung Hyun Tae, Moon Won Lee, Seung Han Kim, Hye-Kyung Jung, Byung-Wook Kim
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2026; 26(1): 23.     CrossRef
  • Dual therapy for Helicobacter pylori infection
    Miao Duan, Jing Liu, Xiuli Zuo
    Chinese Medical Journal.2023; 136(1): 13.     CrossRef
  • Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life Experience
    Bei Tan, Jyh-Chin Yang, Carol L. Young, Shrinivas Bishu, Stephanie Y. Owyang, Mohamad El-Zaatari, Min Zhang, Helmut Grasberger, Jia-ming Qian, John Y. Kao
    Digestive Diseases and Sciences.2018; 63(2): 437.     CrossRef
  • Treatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis
    Sang Wook Lee, Hyun Jung Kim, Jae Gyu Kim
    Journal of Korean Medical Science.2015; 30(8): 1001.     CrossRef
  • 9,729 View
  • 52 Download
  • 4 Crossref
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP